Corcept Therapeutics Incorporated (CORT)

NCM – Real Time Price. Currency in USD

51.16

-0.04 (-0.08%)

At close: May 12, 2026, 4:00 PM EDT

52.05

+0.89 (1.74%)

Pre-market: May 13, 2026, 4:14 AM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

761M

675M

482M

402M

Cost of goods sold

-13M

-11M

-6M

-5M

Gross Profit

748M

664M

476M

396M

Operating expenses (excl. COGS)

-704M

-527M

-369M

-284M

Operating Income

45M

137M

107M

113M

Non-operating income, total

22M

25M

17M

Pretax income

66M

161M

125M

116M

Equity in earnings

Taxes

33M

-20M

-18M

-15M

Non-controlling/minority interest

After tax other income/expense

-1M

-644K

-130K

Net income before discontinued operations

98M

140M

105M

101M

Corcept Therapeutics Incorporated (CORT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Corcept Therapeutics Incorporated (CORT)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Corcept Therapeutics Incorporated (CORT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Corcept Therapeutics Incorporated (CORT)

Income Statement (Annual)

Income Statement (Annual)